Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia-Reference-Cited by-同舟云学术

Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia

Published:2020-02 Issue:2 Volume:26 Page:176-185
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

El Khoury Antoine C.¹,Pilon Dominic²,Morrison Laura²,Shak Nina³,Llaneza Amanda⁴,Kim Edward¹,Lefebvre Patrick²

Affiliation:

1. Janssen Scientific Affairs, Titusville, New Jersey.

2. Analysis Group, Montréal, Quebec, Canada.

3. Analysis Group, Menlo Park, California

4. HireGenics, Duluth, Georgia.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and hospitalizations following rejection, reversal, or payment of the initial once-monthly paliperidone palmitate long-acting injectable antipsychotic claim among patients with schizophrenia or schizoaffective disorder;Journal of Managed Care & Specialty Pharmacy;2024-09

2. A systematic review of the real-world effectiveness and economic and humanistic outcomes of selected oral antipsychotics among patients with schizophrenia in the United States: Updating the evidence and gaps;Journal of Managed Care & Specialty Pharmacy;2024-02-03

3. Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia;Journal of Managed Care & Specialty Pharmacy;2023-08

4. Influencing factors of medication adherence in schizophrenic patients: a meta-analysis;Schizophrenia;2023-05-15

5. Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges;Expert Opinion on Pharmacotherapy;2023-03-04